Amylyx Pharmaceuticals Inc (AMLX)
1.90
+0.14
(+7.95%)
USD |
NASDAQ |
Apr 29, 16:00
1.84
-0.06
(-3.16%)
After-Hours: 06:51
Amylyx Pharmaceuticals Free Cash Flow (Quarterly): 13.20M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 13.20M |
| September 30, 2023 | -5.526M |
| June 30, 2023 | 8.331M |
| March 31, 2023 | -5.322M |
| December 31, 2022 | -50.32M |
| September 30, 2022 | -43.54M |
| Date | Value |
|---|---|
| June 30, 2022 | -47.57M |
| March 31, 2022 | -40.98M |
| December 31, 2021 | -28.43M |
| September 30, 2021 | -21.02M |
| June 30, 2021 | -13.05M |
| March 31, 2021 | -12.66M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-50.32M
Minimum
Dec 2022
13.20M
Maximum
Dec 2023
-20.57M
Average
-17.03M
Median
Free Cash Flow (Quarterly) Benchmarks
| Cassava Sciences Inc | -22.36M |
| iRhythm Technologies Inc | -29.49M |
| Bristol-Myers Squibb Co | 2.55B |
| Moderna Inc | 402.00M |
| ACADIA Pharmaceuticals Inc | 85.39M |